Cell Reports (Jun 2015)

ASXL2 Regulates Glucose, Lipid, and Skeletal Homeostasis

  • Takashi Izawa,
  • Nidhi Rohatgi,
  • Tomohiro Fukunaga,
  • Qun-Tian Wang,
  • Matthew J. Silva,
  • Michael J. Gardner,
  • Michael L. McDaniel,
  • Nada A. Abumrad,
  • Clay F. Semenkovich,
  • Steven L. Teitelbaum,
  • Wei Zou

DOI
https://doi.org/10.1016/j.celrep.2015.05.019
Journal volume & issue
Vol. 11, no. 10
pp. 1625 – 1637

Abstract

Read online

ASXL2 is an ETP family protein that interacts with PPARγ. We find that ASXL2−/− mice are insulin resistant, lipodystrophic, and fail to respond to a high-fat diet. Consistent with genetic variation at the ASXL2 locus and human bone mineral density, ASXL2−/− mice are also severely osteopetrotic because of failed osteoclast differentiation attended by normal bone formation. ASXL2 regulates the osteoclast via two distinct signaling pathways. It induces osteoclast formation in a PPARγ/c-Fos-dependent manner and is required for RANK ligand- and thiazolidinedione-induced bone resorption independent of PGC-1β. ASXL2 also promotes osteoclast mitochondrial biogenesis in a process mediated by PGC-1β but independent of c-Fos. Thus, ASXL2 is a master regulator of skeletal, lipid, and glucose homeostasis.